Study demonstrates liquid biopsy as effective predictor of stage III melanoma relapse and treatment
A study at The University of Texas MD Anderson Cancer Center showed that circulating tumor cells (CTCs), a form of liquid biopsy, was independently associated with melanoma relapse, suggesting CTC assessment may be useful in identifying patients at risk for relapse who could benefit from more aggressive therapy following primary treatment.
Results from the study were published in Clinical Cancer Research, a journal of the American...
Lung cancer screening decision aid delivered through tobacco quitlines improves informed decision-making
In the first comparative clinical trial of lung cancer screening decision aid versus standard educational information, researchers from The...
MD Anderson’s deemed status restored; re-accreditation completed
The University of Texas MD Anderson Cancer Center has announced that the Texas Health and Human Services Commission, on behalf of the Centers...
Craig Owen Named Chief Information Officer
The University of Texas MD Anderson Cancer Center today named Craig Owen as its chief information officer. Owen has served the institution since 1992, most recently as chief information officer ad interim beginning in 2017. His nearly three decades of experience in Information Services will play a crucial role in strengthening MD Anderson's commitment to achieving its mission to end cancer through technology.
"Craig'...
B-cell enrichment predictive of immunotherapy response in melanoma, sarcoma and kidney cancer
The likelihood of a patient responding to immune checkpoint blockade may depend on B cells in the tumor, located within specialized immune-cell...
Study shows protein inhibitor as potential treatment approach for common mutations found in non-Hodgkin lymphomas
A study at The University of Texas MD Anderson Cancer Center demonstrated a potential new approach to treating two of the most common subtypes...